Revelation Biosciences (REVB) Cash & Equivalents (2020 - 2026)
Revelation Biosciences (REVB) reported Cash & Equivalents of $11.5 million for Q2 2026, up 121.2% from $5.2 million a year earlier but down 18.5% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Revelation Biosciences posted Cash & Equivalents of $10.7 million, up 64.6% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 290.8% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $6.5 million in FY2024 (-45.8%), $11.99 million in FY2023 (+128.3%), $5.25 million in FY2022 (+312.1%) and $1.27 million in FY2021.
- Five-year quarterly Cash & Equivalents spans a low of $1.27 million in Q4 2021 and a high of $17.7 million in Q1 2023.
- Year over year, Cash & Equivalents has now increased in each of the last four quarters, with growth averaging 41.3% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2023 (growth of 348.9%); the low point was Q1 2025 (a decline of 74.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14.11 million (Q1 2026), $10.7 million (Q4 2025) and $12.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Revelation Biosciences | 3.13 Mn | -45.90 Mn | - | 11.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.50 Mn |
| Mar 31, 2026 | 14.11 Mn |
| Dec 31, 2025 | 10.70 Mn |
| Sep 30, 2025 | 12.71 Mn |
| Jun 30, 2025 | 5.20 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | 6.50 Mn |
| Sep 30, 2024 | 6.54 Mn |
| Jun 30, 2024 | 12.10 Mn |
| Mar 31, 2024 | 14.60 Mn |
| Dec 31, 2023 | 11.99 Mn |
| Sep 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 15.71 Mn |
| Mar 31, 2023 | 17.70 Mn |
| Dec 31, 2022 | 5.25 Mn |
| Sep 30, 2022 | 6.20 Mn |
| Jun 30, 2022 | 3.50 Mn |
| Mar 31, 2022 | 7.20 Mn |
| Dec 31, 2021 | 1.27 Mn |
| Dec 31, 2020 | 11,734.00 |
API Access
Revelation Biosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();